SOD1 and myeloid sarcoma: Pre-treatment with MS (100 or 200 mg kg−1, p.o.)markedly reduced cerebral infarct size, XO, O•−2 and TBARS levels, significantly restored GSH, SOD and T-SH levels and attenuated impairment in short-term memory and motor coordination.